NAD+ NJ1000 1000mg*10vials

NAD+ NJ1000 1000mg*10 vials (nicotinamide adenine dinucleotide, oxidized form) is an industry-exclusive, limited-edition flagship product in the NAD+ coenzyme metabolism longevity peptide series, considered the pinnacle of ultra-limited upgraded versions, surpassing high-end versions such as NJ100 and NJ500. NAD+, as a core endogenous coenzyme regulating all cellular biochemical reactions, energy metabolism, DNA gene repair, and longevity epigenetic regulation, is the core engine of cellular life activities. The unprecedented 1000mg ultra-high saturation dose breaks through the efficacy limits of traditional high-concentration NAD+ products, fully activating the Sirtuins full-spectrum longevity pathway, the PARP ultra-high-load DNA repair system, and the mitochondrial respiratory chain complex. NJ1000 possesses zero immunogenicity, extreme biochemical stability, and excellent cell compatibility, providing ultra-limited coenzyme reserve support for intervention in extreme end-stage organ metabolic failure, construction of irreversible deep multi-organ aging models, repair of refractory severe oxidative inflammation cascade damage, and top-tier ultra-synergistic systemic longevity resetting research using super-complex peptides. It is a top-tier, premium research material exclusively used in cutting-edge research such as advanced metabolic pharmacology, the study of mechanisms of degenerative diseases, and ultra-precise gene repair.

Product Functions and Research Value

In ultra-intensive, high-load, systematic laboratory research, NAD+ NJ1000 1000mg demonstrates remarkable regulatory efficacy across seven dimensions, completely surpassing the limits of intervention offered by existing NJ series products. Its core, top-tier research advantages encompass seven exclusive, ultra-dimensional aspects: 100% supersaturated intracellular NAD+ pool filling, completely reversing the cumulative depletion of end-stage coenzymes; explosive, comprehensive activation of the entire Sirtuins family, achieving complete eradication of epigenetic aging and ultimate reshaping of systemic metabolism; full-load, ultra-high-frequency PARP super-system activation, maximizing the precise identification and thorough repair of massive amounts of irreversible, cumulative DNA damage; ultra-amplitude optimization of mitochondrial TCA cycle and oxidative phosphorylation, unlocking the peak limit of ATP energy output and completely terminating lifelong chronic cellular energy exhaustion; thorough elimination of deep-seated accumulated oxidative stress and stubborn, persistent inflammatory cascade responses, rebuilding a super-strong cellular stress homeostasis; comprehensive immune and metabolic reset, blocking the irreversible degenerative aging process of multiple organs; and ultimate regulation of cell cycle aging signals, achieving systemic vitality supremacy. Reversal. Authoritative scientific research confirms that the level of NAD+ in human cells undergoes an irreversible, precipitous decline with age, leading to mitochondrial dysfunction, metabolic paralysis, accumulation of massive gene damage, and systemic, comprehensive aging. This historic 1000mg ultra-high dose formulation achieves unprecedented complete coenzyme saturation coverage, uniquely targeting and intervening in end-stage refractory severe metabolic paralysis, irreversible mitochondrial energy depletion, massive deep gene damage deposition, and advanced multi-organ aging lesions completely insensitive to NJ500 ultra-high saturation formulations. It fundamentally resets the entire cellular biochemical cycle system, maximizing the ultimate activation efficiency of all longevity and repair pathways, achieving a supreme systemic cellular vitality reversal effect that no medium, high, or ultra-high dose NAD+ formulation can reach. This exclusive ultra-high dose ultimate specification boasts extremely high amplitude experimental phenotypes, permanent zero-attenuation super-potency efficacy, and multi-pathway synergistic explosive activation capabilities, perfectly matching the ultimate dose threshold screening, key modeling of end-stage systemic metabolic degeneration, intervention in irreversible multi-organ advanced aging, and validation of ultimate longevity through top-tier super-synergistic peptides. It provides exclusive, top-tier, ultra-high discrimination, authoritative, and reproducible upper limit data for cutting-edge preclinical research on extreme metabolism and deep longevity globally.

Core Product Advantages

1. Exclusive Ultra-Limited Coenzyme Supersaturation: The industry-leading 1000mg ultimate dose completely breaks through the saturation limit of NJ500's ultra-high specifications, achieving 100% complete coverage and superfilling of intracellular NAD+ reserve gap, triggering a full-scale activation of all downstream metabolism, longevity, epigenetics, etc.